Dublin, Feb. 24, 2022 (GLOBE NEWSWIRE) -- The "Scar Treatment Market Share, Size, Trends, Industry Analysis Report, By Product [Topical Products, Laser Products, Injectables, Others], By Scar Type, By End-Use; By Region; Segment Forecast, 2021 - 2029" report has been added to ResearchAndMarkets.com's offering.
The global scar treatment market size is expected to reach USD 26.76 billion by 2029 according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.
Prominent market factors such as the increasing awareness regarding the numerous wound treatment options coupled with the growing number of burn injuries and road accidents are propelling the market demand. Besides, rising demand for enhancing aesthetic appeal for skin rejuvenation and escalating incidences of hypertrophic burn marks is expected to complement the marks treatment market growth.
Based on product, the topical products segment holds the largest revenue in 2020, owing to the easy availability of topical creams, gels, and silicone sheets as Over-the-Counter (OTC) products that facilitate people to use them for curing marks.
Whereas, the laser products segment is projected to rise at the fastest rate over the forecast period as they are widely adopted as they offer a non-invasive and painless alternative for the healing of wounds. Therefore, these various benefits of the laser products lead the segment growth in the foreseen years.
Numerous organizations such as Scar After-Care and Research (OSCARE), European Dermatology Congress, Organization for Burns, and The American Society for Laser Medicine & Surgery Inc. (ASLMS) are encouraging and making aware people for the adoption of the wound treatment.
These associations organize several conferences comprises the 20th European Dermatology Congress (scheduled in April 2020), Global Meet on Skin Care and Plastic Aesthetics (held in November 2020), and the ASLMS Conference 2019 on Energy-Based Medicine and Science. Consequently, these initiatives by the various companies and associations act as a catalyzing factor for the treatment market growth.
Industry participants such as Smith & Nephew PLC, Suneva Medical, Lumenis, CCA Industries, Inc., Merz Pharmaceuticals, LLC, Molnlycke Health Care AB, Sonoma Pharmaceuticals, Inc., Newmedical Technology Inc., and Cynosure are some of the key players operating in the global industry.
In April 2021, Pharmaxis- an Australian pharmaceutical research company- collaborated with the University of Western Australia (UWA) to commence a first-of-its-kind clinical trial for scrutinizing a cream to prevent marks from forming. A well-known surgeon burns expert directed this trial, and researchers for its candidate "PXS-6302" are exhibiting promising results in limiting enzymes that act as a catalyst in developing marks.
Key Topics Covered:
1. Introduction
2. Executive Summary
3. Research Methodology
4. Global Scar Treatment Market Insights
4.1. Scar Treatment - Industry Snapshot
4.2. Scar Treatment Market Dynamics
4.2.1. Drivers and Opportunities
4.2.2. Restraints and Challenges
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Scar Treatment Market Industry Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Scar Treatment Market, by Product
5.1. Key Findings
5.2. Introduction
5.2.1. Global Scar Treatment Market, by Product, 2017 - 2029 (USD Million)
5.3. Topical Products
5.3.1. Global Scar Treatment Market, by Topical Products, by Region, 2017 - 2029 (USD Million)
5.3.2. Creams
5.3.2.1. Global Scar Treatment Market, by Creams, by Region, 2017 - 2029 (USD Million)
5.3.3. Gels
5.3.3.1. Global Scar Treatment Market, by Gels, by Region, 2017 - 2029 (USD Million)
5.3.4. Silicon Sheets
5.3.4.1. Global Scar Treatment Market, by Silicon Sheets, by Region, 2017 - 2029 (USD Million)
5.3.5. Others
5.3.5.1. Global Scar Treatment Market, by Others, by Region, 2017 - 2029 (USD Million)
5.4. Laser Products
5.4.1. Global Scar Treatment Market, by Laser Products, by Region, 2017 - 2029 (USD Million)
5.4.2. CO2 Laser
5.4.2.1. Global Scar Treatment Market, by CO2 Laser, by Region, 2017 - 2029 (USD Million)
5.4.3. Pulse-dyed Laser
5.4.3.1. Global Scar Treatment Market, by Pulse-dyed Laser, by Region, 2017 - 2029 (USD Million)
5.4.4. Others
5.4.4.1. Global Scar Treatment Market, by Others, by Region, 2017 - 2029 (USD Million)
5.5. Injectables
5.5.1. Global Scar Treatment Market, by Injectables, by Region, 2017 - 2029 (USD Million)
5.6. Others
5.6.1. Global Scar Treatment Market, by Others, by Region, 2017 - 2029 (USD Million)
6. Global Scar Treatment Market, by Scar Type
6.1. Key Findings
6.2. Introduction
6.2.1. Global Scar Treatment Market, by Scar Type, 2017 - 2029 (USD Million)
6.3. Atrophic Scars
6.3.1. Global Scar Treatment Market, by Atrophic Scars, by Region, 2017 - 2029 (USD Million)
6.4. Hypertrophic & Keloid Scars
6.4.1. Global Scar Treatment Market, by Hypertrophic & Keloid Scars, by Region, 2017 - 2029 (USD Million)
6.5. Contracture Scars
6.5.1. Global Scar Treatment Market, by Contracture Scars, by Region, 2017 - 2029 (USD Million)
6.6. Stretch Marks
6.6.1. Global Scar Treatment Market, by Stretch Marks, by Region, 2017 - 2029 (USD Million)
7. Global Scar Treatment Market, by End-Use
7.1. Key Findings
7.2. Introduction
7.2.1. Global Scar Treatment Market, by End-Use, 2017 - 2029 (USD Million)
7.3. Hospitals
7.3.1. Global Scar Treatment Market, by Hospitals, By Region, 2017 - 2029 (USD Million)
7.4. Clinics
7.4.1. Global Scar Treatment Market, by Clinics, By Region, 2017 - 2029 (USD Million)
7.5. Retail Pharmacies/ E-commerce
7.5.1. Global Scar Treatment Market, by Retail Pharmacies/E-commerce, By Region, 2017 - 2029 (USD Million)
8. Global Scar Treatment Market, by Geography
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Smith & Nephew PLC
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. Suneva Medical
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. Lumenis
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. CCA Industries, Inc.
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. Merz Pharmaceuticals, LLC
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Molnlycke Health Care AB
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Sonoma Pharmaceuticals, Inc.
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Newmedical Technology Inc.
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Cynosure
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
For more information about this report visit https://www.researchandmarkets.com/r/i4lgzh
Attachment
